A 12-week study of TS-071, a selective SGLT2 inhibitor, in Japanese patients with type 2 diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2014
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 01 Jul 2011 New trial record
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History